{"id":"https://openalex.org/W7225564131","doi":"https://doi.org/10.70164/bjoh.v3i3.316","title":"Agonistas de GLP-1 como potenciais agentes neuroprotetores: avan\u00e7os e perspectivas no tratamento de doen\u00e7as neurodegenerativas","display_name":"Agonistas de GLP-1 como potenciais agentes neuroprotetores: avan\u00e7os e perspectivas no tratamento de doen\u00e7as neurodegenerativas","publication_year":2026,"publication_date":"2026-11-08","ids":{"openalex":"https://openalex.org/W7225564131","doi":"https://doi.org/10.70164/bjoh.v3i3.316"},"language":"pt","primary_location":{"id":"doi:10.70164/bjoh.v3i3.316","doi":"https://doi.org/10.70164/bjoh.v3i3.316","is_oa":true,"landing_page_url":"https://doi.org/10.70164/bjoh.v3i3.316","pdf_url":"https://brjohealth.com/index.php/ojs/article/download/316/280","source":{"id":"https://openalex.org/S5407049696","display_name":"Brazilian Journal of One Health","issn_l":"3085-6337","issn":["3085-6337"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4404677168","host_organization_name":"Nilton Lins University","host_organization_lineage":["https://openalex.org/P4404677168"],"host_organization_lineage_names":["Nilton Lins University"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brazilian Journal of One Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://brjohealth.com/index.php/ojs/article/download/316/280","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113193476","display_name":"Pietro Matheus Oliveira Mota","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Matheus Oliveira Mota","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152010986","display_name":"Maria Elisa Silva Malinski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Elisa Silva Malinski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152004369","display_name":"Isadora Lopes da Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isadora Lopes da Silva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152006157","display_name":"Beatriz Bomfim Wiltemb\u00fcrg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatriz Bomfim Wiltemb\u00fcrg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152027798","display_name":"Sofia Tavares Alves","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sofia Tavares Alves","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100595036","display_name":"Layza Lopes da Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Layza Lopes da Silva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.10040000081062317,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.06300000101327896,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.996999979019165},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":1.0},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8619999885559082},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":1.0},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.49399998784065247},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4740000069141388},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3889000117778778},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3653999865055084},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36239999532699585},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2847999930381775},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.26910001039505005},{"id":"https://openalex.org/C2778117688","wikidata":"https://www.wikidata.org/wiki/Q264024","display_name":"Animal model","level":2,"score":0.26010000705718994},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2410999983549118},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.21279999613761902},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2029999941587448}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.70164/bjoh.v3i3.316","doi":"https://doi.org/10.70164/bjoh.v3i3.316","is_oa":true,"landing_page_url":"https://doi.org/10.70164/bjoh.v3i3.316","pdf_url":"https://brjohealth.com/index.php/ojs/article/download/316/280","source":{"id":"https://openalex.org/S5407049696","display_name":"Brazilian Journal of One Health","issn_l":"3085-6337","issn":["3085-6337"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4404677168","host_organization_name":"Nilton Lins University","host_organization_lineage":["https://openalex.org/P4404677168"],"host_organization_lineage_names":["Nilton Lins University"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brazilian Journal of One Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.70164/bjoh.v3i3.316","doi":"https://doi.org/10.70164/bjoh.v3i3.316","is_oa":true,"landing_page_url":"https://doi.org/10.70164/bjoh.v3i3.316","pdf_url":"https://brjohealth.com/index.php/ojs/article/download/316/280","source":{"id":"https://openalex.org/S5407049696","display_name":"Brazilian Journal of One Health","issn_l":"3085-6337","issn":["3085-6337"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4404677168","host_organization_name":"Nilton Lins University","host_organization_lineage":["https://openalex.org/P4404677168"],"host_organization_lineage_names":["Nilton Lins University"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brazilian Journal of One Health","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225564131.pdf","grobid_xml":"https://content.openalex.org/works/W7225564131.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414313078","https://openalex.org/W7224789720","https://openalex.org/W7114990296","https://openalex.org/W4387168369","https://openalex.org/W7166658105","https://openalex.org/W4415936414","https://openalex.org/W4409662044","https://openalex.org/W7166979181","https://openalex.org/W4413920580","https://openalex.org/W2927288321"],"abstract_inverted_index":{"As":[0],"doen\u00e7as":[1,140],"neurodegenerativas":[2],"representam":[3],"um":[4],"importante":[5],"desafio":[6],"\u00e0":[7,11,105],"sa\u00fade":[8],"p\u00fablica":[9],"devido":[10],"sua":[12,57,157],"natureza":[13],"progressiva":[14],"e":[15,59,85,112,143,170],"\u00e0s":[16],"limita\u00e7\u00f5es":[17],"das":[18,139],"terapias":[19],"dispon\u00edveis.":[20],"Nesse":[21],"contexto,":[22],"os":[23,48,125,148,171],"agonistas":[24,149],"do":[25,27,109],"receptor":[26],"pept\u00eddeo":[28],"semelhante":[29],"ao":[30],"glucagon":[31],"tipo":[32],"1":[33],"(GLP-1)":[34],"t\u00eam":[35],"despertado":[36],"interesse":[37],"por":[38],"seus":[39],"poss\u00edveis":[40,118],"efeitos":[41,135],"neuroprotetores.":[42],"O":[43],"presente":[44],"estudo":[45],"objetivou":[46],"analisar":[47],"mecanismos":[49,102],"de":[50,56,62,71,78,97,117,134,141,144,150,161],"neuroprote\u00e7\u00e3o":[51],"desses":[52],"medicamentos,":[53],"as":[54,60],"evid\u00eancias":[55],"efic\u00e1cia":[58],"perspectivas":[61],"aplica\u00e7\u00e3o":[63,158],"terap\u00eautica.":[64],"Realizou-se":[65],"uma":[66],"revis\u00e3o":[67],"integrativa":[68],"da":[69,107,113,137],"literatura,":[70],"abordagem":[72],"qualitativa,":[73],"mediante":[74],"busca":[75],"na":[76],"base":[77],"dados":[79],"PubMed,":[80],"considerando":[81],"publica\u00e7\u00f5es":[82],"entre":[83],"2021":[84],"2026.":[86],"Foram":[87],"identificados":[88],"33":[89],"artigos,":[90],"dos":[91],"quais":[92],"seis":[93],"atenderam":[94],"aos":[95],"crit\u00e9rios":[96],"elegibilidade.":[98],"Os":[99],"resultados":[100,129],"evidenciaram":[101],"promissores":[103],"relacionados":[104],"redu\u00e7\u00e3o":[106],"neuroinflama\u00e7\u00e3o,":[108],"estresse":[110],"oxidativo":[111],"disfun\u00e7\u00e3o":[114],"mitocondrial,":[115],"al\u00e9m":[116],"benef\u00edcios":[119,172],"sobre":[120],"a":[121,166,168],"integridade":[122],"neuronal.":[123],"Entretanto,":[124],"ensaios":[126],"cl\u00ednicos":[127],"apresentaram":[128],"heterog\u00eaneos,":[130],"sem":[131],"comprova\u00e7\u00e3o":[132],"consistente":[133],"modificadores":[136],"progress\u00e3o":[138],"Alzheimer":[142],"Parkinson.":[145],"Concluiu-se":[146],"que":[147,164],"GLP-1":[151],"apresentam":[152],"potencial":[153],"neuroprotetor":[154],"relevante,":[155],"embora":[156],"cl\u00ednica":[159],"dependa":[160],"investiga\u00e7\u00f5es":[162],"adicionais":[163],"confirmem":[165],"efic\u00e1cia,":[167],"seguran\u00e7a":[169],"terap\u00eauticos":[173],"prolongados.":[174]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}